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ABSTRACT 
 
Objectives: Post-menopausal hot flushes occur due to a reduction in oestrogen production 
causing thermoregulatory and vascular dysfunction.
 
Exercise training enhances 
thermoregulatory control of sweating, skin and brain blood flow. We aimed to determine if 
improving thermoregulatory control and vascular function with exercise training alleviated 
hot flushes.  
 
Methods: Twenty one symptomatic females completed a 7-day hot flush questionnaire and 
underwent brachial artery flow-mediated dilation and a cardiorespiratory fitness test. Sweat 
rate and skin blood flow temperature thresholds and sensitivities, and middle cerebral artery 
velocity (MCAv) was measured during passive heating. Females performed 16-weeks of 
supervised exercise training or control, and measurements were repeated.  
 
Results: There was a greater improvement in cardiorespiratory fitness (4.45 ml·kg
-1
·min
-1
 
(95% CI: 1.87, 8.16; P=0.04) and reduced hot flush frequency [48 hot flushes·week (39, 56) 
P<0.001] following exercise compared to control. Exercise reduced basal core temperature 
[0.14°C (0.01, 0.27) P=0.03] and increased basal MCAv [2.8 cm/s (1.0 to 5.2) P=0.04] 
compared to control. Sweat rate and skin blood flow thresholds occurred ~0.19 and 0.17°C 
earlier, alongside improved sweating sensitivity with exercise. MCAv decreased during 
heating [P<0.005], but was maintained 4.5 cm/s (3.6, 5.5 P<0.005) higher during heating 
following exercise compared to control [0.6 cm/s (-0.4, 1.4)].  
 
Conclusions: Exercise training that improves cardiorespiratory fitness reduces self-reported 
hot flushes. Improvements are likely mediated through greater thermoregulatory control in 
response to increases in core temperature and enhanced vascular function in the cutaneous 
and cerebral circulations.  
 
 
KEY WORDS: Hot flushes; exercise training; vascular function; thermoregulation; brain 
blood flow 
 
  
INTRODUCTION 
Hot flushes are experienced by the vast majority of menopausal women and are associated 
with increased cardiovascular disease risk 
1
. Menopausal hot flushes can seriously disrupt the 
lives of symptomatic females 
2
 with ~70% of females experiencing hot flushes 1-5 years after 
the onset of the menopause 
3
. A hot flush is typically defined as the subjective sudden intense 
sensation of heat causing cutaneous vasodilation and profuse sweating
 4
. Hormone therapy 
(HT) is an effective treatment for hot flushes and can reduce hot flush frequency by 50-72% 
5,6
 but has poor uptake
7
. Furthermore, not all females can be prescribed HT due to time since 
the menopause and a history of cardiovascular disease or breast cancer 
8
. The current 
alternatives are limited but one non-pharmacological option is exercise training.  
 
The mechanisms causing hot flushes are not completely understood, yet it is thought that the 
reduction in oestrogen due to ovarian failure causes thermoregulatory and vascular 
dysfunction, leading to the occurrence of hot flushes 
9
.  An elevation in basal core body 
temperature and a narrowed thermo-neutral zone are thought to be primary explanations 
2
, 
with a reduced skin vascular reactivity to increases in core body temperature also proposed as 
a mediator 
9,10
. No research study to date has simultaneously investigated the impact of 
exercise training on thermoregulatory and vascular dysfunction observed in symptomatic 
post-menopausal females and the effect of improvements in these systems on hot flush 
symptomology. 
 
A number of research studies, but not all, have shown exercise training can reduce the 
frequency of self-reported hot flushes 
11-17
 and improve other non-vasomotor symptoms 
including depression, anxiety and insomnia 
14,18,19
. Nevertheless, these studies have solely 
relied on subjective questionnaires as the primary outcome. It is also important to highlight 
that the most recent randomised control trial investigating the impact of exercise training 
(home based and general advice) using subjective frequency of hot flushes reported a lack of 
impact of exercise training despite finding a clinically meaningful decrease of 9 weekly hot 
flushes compared to control 
17
. 
 
It is well established that exercise training can improve the thermoregulatory control system 
by decreasing core body temperature, and by changing both the temperature threshold for the 
onset, and sensitivity of sweating and cutaneous vasodilation in pre-menopausal females 
20
.  
Whilst HT reduces hot flushes it also affects thermoregulatory control mechanisms via 
lowering core body temperature and altering the threshold at which cutaneous vasodilation 
and sweating responses are initiated 
21,22
. If the thermoregulatory control system can be 
altered with exercise training in symptomatic post-menopausal women, this may also reduce 
the frequency of hot flushes. Moreover, exercise training improves endothelial function in the 
cutaneous and conduit vessels in post-menopausal females 
23-25
, and cerebral blood flow 
(CBF) in older individuals 
26,27
. Endothelial dysfunction is associated with hot flush severity 
28
, suggesting that if endothelial function is improved with exercise training this may 
contribute to a reduction in the occurrence and severity of hot flushes. Therefore, the aim of 
this study was to determine whether improving thermoregulatory control and systemic 
vascular function with exercise training alleviates the frequency and severity of menopausal 
hot flushes. We hypothesised that exercise training reduces the frequency and severity of hot 
flushes via improving sweat rate and skin blood flow responses to increases in core body 
temperature. 
METHODS 
Participants 
Twenty-one symptomatic post-menopausal females were recruited from the gynaecology and 
reproductive medicine clinic at Liverpool Women’s Hospital, local G.P. practices and via 
local advertisement. Participants were 1-4 years since their last menstrual period and suffered 
>4 hot flushes over a 24h period. All participants had no history of diabetes, cardiovascular 
or respiratory disease, were non-smokers, drank <14 units of alcohol per week, and had no 
contraindications to exercise. Participants who had used HT, metformin, vasoactive or BP 
lowering medications within the last 6 months were excluded from the study. Similarly, 
females who were currently taking part in regular exercise (>2h a week based on a self-
reported questionnaire) were also excluded. Participants were informed of the methods 
verbally and in writing before providing written informed consent. The study conformed to 
the Declaration of Helsinki and was approved by the local research ethics committee.  
Research Design 
Participants reported to the laboratory on two separate occasions, and were asked to fast 
overnight, refrain from alcohol and exercise for 24h and caffeine for 12h before each visit. 
Visit one included anthropometric measurements, assessment of brachial artery endothelial 
function using Flow-Mediated Dilation (FMD) and a cardiorespiratory test (VO2peak). Visit 2 
consisted of a fasting blood sample and a passive heat stress challenge to assess 
thermoregulatory, haemodynamic and cerebrovascular responses to increases in core body 
temperature. Both visits were completed within 7 days of each other with assessments 
conducted in a temperature-controlled laboratory (24±1°C). Participants then underwent a 
supervised exercise training intervention or a no-exercise control that was based on 
participant choice. Fourteen (n=14, 52±4y, BMI; 21.1-41.8 kg/m
2
) symptomatic females 
received a 16-week programme of supervised moderate-intensity aerobic exercise training 
while seven (n=7, 52±6y, 21.1-41.3 kg/m
2
) symptomatic females comprised the no-exercise 
control group. Following each intervention all measurements were repeated.   
 
Measurements 
Hot Flush Frequency and Severity Questionnaire 
Participants completed a 7-day hot flush frequency and severity diary 
29
 prior to, and 
following the 16-week intervention period. Participants recorded on a daily basis how many 
hot flushes they experienced as well as information regarding the severity of each hot flush 
on a scale of 1-4 (1 being mild, 2 moderate, 3 severe and 4 very severe). From this, a 7 day 
sum of hot flushes provided a weekly hot flush score. A daily severity score was calculated 
by the sum of hot flushes recorded into each severity rating i.e. 
[(3*1(mild))+(4*2(moderate))+(1*3(severe))+(0*4(very severe)) = daily severity score of 
14].  A hot flush severity index was then calculated by the total sum of daily severity scores 
over the 7 day period. The use of subjective diaries is established as a valid approach to 
obtaining data on subjective hot flushes when reporting patient symptoms and perceptions 
29
 
and in a number of hot flush research studies 
11,12,16,30
.  
Cardiorespiratory assessment for peak oxygen consumption 
A fitness test (peak oxygen uptake; VO2peak) was performed on a treadmill following a 
modified Bruce protocol. Following a 2-min warm-up at 2.2 km h
-1 
on a flat gradient, the 
initial workload was set at 2.7 km h
-1 
at a 5° gradient. Thereafter, stepwise increments in 
speed and gradient were performed each minute until volitional exhaustion. Heart rate (12-
lead ECG) and rate of perceived exertion were monitored throughout. Peak oxygen uptake 
was calculated from expired gas fraction (Oxycon Pro, Jaegar, Hochberg Germany) as the 
highest consecutive 15s period of data in the final minute before volitional exhaustion. 
 
Brachial artery endothelial-dependent vasodilation 
Brachial artery endothelium-dependent function was measured using the flow-mediated 
dilation (FMD) technique 
31
. Measurements were performed in the supine position following 
20 min of rest and are described in detail elsewhere 
31
. Following a 1 min recording period of 
resting diameter and flow, a rapid inflation pneumatic cuff (D.E Hokanson, Bellevue, UK), 
positioned on the forearm immediately distal to the olecranon process was inflated (>200 
mmHg) for 5 min to provide a stimulus for forearm ischemia.  Diameter and flow recordings 
resumed 30 sec prior to cuff deflation and continued for 3 min thereafter, in accordance with 
recent technical specifications 
32,33
. 
 
Analysis of brachial artery diameter was performed using custom-designed edge-detection 
and wall-tracking software, which is largely independent of investigator bias. Recent papers 
contain detailed descriptions of the analysis approach 
31,32
. From synchronised diameter and 
velocity data, blood flow (the product of lumen cross- sectional area and Doppler velocity) 
were calculated at 30 Hz. Shear rate (an estimate of shear stress without viscosity) was 
calculated as 4 times mean blood velocity/vessel diameter. Reproducibility of diameter 
measurements using this semi-automated software is significantly better than manual 
methods, reduces observer error significantly, and possesses an intra-observer CV of 6.7% 
34
.  
We also controlled for the baseline diameter measured before the introduction of hyperemia 
in each test of FMD. This allometric approach is more accurate for scaling changes in 
diameter than simple percentage change, which makes implicit assumptions about the 
relationship between baseline diameter and peak diameter 
35
. 
 
Passive heat stress challenge 
Participants were placed in a tube-lined jacket and trousers (Med-Eng., Ottawa, Canada), 
which covered the entire body except for the head, feet and the right forearm. Participants 
rested quietly in a semi-recumbent position while water (34°C) was perfused through the suit 
for a 15 min baseline period. Participants were then exposed to a moderate heat stress by 
perfusing water at 48
o
C through the suit for 60 min or until a rise of ~1°C in core body 
temperature. The following measurements were taken during the baseline and heating 
periods. 
 
Heart rate was obtained from a 3-lead electrocardiogram (Powerlab, AD Instruments, Oxford, 
UK), alongside continuous beat-by-beat finger arterial blood pressure (BP) (Finapress, 
Amsterdam, Netherlands). Stroke volume (SV) and cardiac output (CO) were calculated 
using the BP waveform using the Modelflow method, incorporating age, height, sex and 
weight (Beatscope 1.0 software, TNO, Biomedical Instruments). To verify continuous BP 
measured at the finger, an automated BP (Dinamap, Germany) reading was collected at 
regular intervals. Mean skin temperature was obtained from the weighted average of 4 
regional temperatures measured from thermocouples (iButtons data logger, Maxim 
Integrated; San Jose, CA, US) secured to the lateral calf, lateral thigh, upper arm and chest 
36
. 
Core body temperature was measured from an ingestible pill telemetry system taken ~5 h 
before data collection began (CoreTemp, HQInc; Palmetto, FL, US), with the ingestion time 
recorded and repeated for each participant’s pre and post trials. Mean body temperature was 
calculated using the weighted product of core and mean skin temperatures 
37
. 
 
Local sweat rate was recorded continuously from the dorsal forearm and the mid-sternum 
(not covered by the water-perfused suit) using capacitance hygrometry. Dry 100% nitrogen 
gas was supplied through acrylic capsules (surface area= 2.32cm
2
) attached to the skin’s 
surface at a flow rate of 300mL/min, with the humidity of the gas flowing out of the capsules 
measured by the capacitance hygrometer (Viasala HMP155, Helsinki, Finland). Local skin 
blood flow (SkBF) was also measured at the chest and the forearm, using laser-Doppler 
flowmetry (Periflux System 5001, Perimed; AB, Sweden). Laser-Doppler flow probes were 
affixed with an adhesive heating ring in close proximity to the ventilated sweat rate capsule. 
Cutaneous vascular conductance (CVC) was calculated as the ratio of laser-Doppler flux 
units to mean arterial pressure (MAP) and expressed as both CVC and a percentage of 
maximum CVC (%CVCmax).  
 
Middle cerebral artery blood velocity (MCAV; 1 cm distal to the MCA-anterior cerebral 
artery bifurcation) was measured continuously through the temporal window using 
transcranial Doppler ultrasonography. A 2-MHz Doppler probe (Spencer Technologies, 
Seattle WA, USA) was adjusted until an optimal signal was identified, as described in detail 
previously 
38-40
, and held in place using a headband strap to prevent subtle movement of the 
Doppler probe and maintain insonation angle accuracy. Once the optimal MCA signal was 
attained in the temporal window, the probe location and machine settings (depth, gain and 
power) were recorded to identify the same imaging site during post-intervention assessments. 
Using these guidelines this technique is a valid and reliable index of cerebral blood flow 
38
. 
Participants were instrumented with a two-way valve-breathing mouthpiece from which peak 
end tidal CO2 (PETCO2) was measured every 5 min and at each 0.1°C increase in core body 
temperature. An index of cerebrovascular conductance (CBVC) was calculated from the ratio 
of MCAV to MAP. All data were calculated as 60 sec averages at every 0.1°C increase in core 
temperature during heating. All data during the heat stress challenge were sampled at 50Hz 
with a data acquisition system (PowerLab, ADInstruments, Oxford UK).  
 
Following the passive heat stress, local skin heating was performed simultaneously at the 
chest and forearm laser Doppler flowmetry sites to assess maximal cutaneous blood flow. 
Temperature of the local heating units was increased at a rate of 0.5 °C every 5 sec to a 
temperature of 42 °C. This resulted in an increase in skin temperature to ~42 °C at the heating 
probe-skin surface interface. The protocol was complete once flux at both sites had reached a 
stable plateau (~30 min).  
 
Data Reduction 
The temperature thresholds for the onset of sweating (mean body temperature) and cutaneous 
vasodilation (core body temperature) were calculated in a blinded fashion by the same analyst 
41
. The sensitivity of the sweating responses were estimated from the slope of the 
relationships between sweat rate per unit change in mean body temperature beyond the mean 
body temperature threshold, and any sweat rate plateau, or increase during a hot flush 
episode, were excluded from the slope calculation. Skin blood flow sensitivity was estimated 
in the same way, instead using the rate of CVC per unit change in core temperature.  
 
Supervised Exercise Training Intervention 
Before commencing the exercise intervention, all participants attended a thorough 
familiarisation session. Participants were required to attend the University gym on a weekly 
basis during which time they wore a heart rate monitor (Polar Fitness, Polar Electro Oy, 
Finland) and were provided with full exercise supervision and guidance from a trained 
exercise physiologist. During these sessions, participants were issued with a weekly 
progressive exercise programme that was specific to their own rate of progression 
42,43
. On 
the basis of individual fitness level, participants underwent 30min of moderate-intensity 
aerobic exercise three-times per week (30% heart rate reserve (HRR)), which progressed 
weekly based on HR responses and included treadmill walking/running, cycling, cross-
training and rowing. At week 12, participants were exercising 4-5 times per week for 45 min 
at 60%HRR. To facilitate compliance throughout the 16-week intervention, participants were 
monitored via the Wellness Key® system, a software programme that enables remote and 
accurate tracking of exercise activity. A moderate-intensity programme was used in line with 
NHS guidelines and our previous studies that have shown improvements in cardiorespiratory 
fitness 
23,42-44
.  
 
Control Intervention 
After consent and physiological flush assessment, women who opted for the control group 
had little contact with the research team throughout the 16-weeks. The research team did not 
influence lifestyle during the 16-week period. This type of control intervention reflects 
current convention care for non-pharmacological hot flush treatment in the UK.   
Statistical Analyses 
For comparison of exercise vs control, delta changes (∆) from pre-intervention were 
calculated for each group and entered as the dependent variable in a linear mixed model 
(ANCOVA), with pre-intervention data entered as a covariate, this allows all differences 
between changes to be covariate-adjusted for the pre-intervention values
45
. This analysis 
approach is more statistically precise and adjusts properly for any study group imbalances at 
pre intervention. Ultimately, this analysis provides one P value for the effect of intervention, 
which is adjusted for the pre-intervention values. Data are presented in the text for 
intervention adjusted effects as mean and 95% confidence intervals.  Data in the tables are 
absolute values (point estimates) for v pre and post-intervention and are presented as mean 
(SD). Correlations between the ∆ intervention changes in hot flush frequency and SR and 
CVC thresholds were quantified using Pearson’s correlation coefficient.  
 
For comparison of exercise verses control during the passive heat stress a three-factor 
((group*0.1ºC increase*time(pre/post intervention)) linear mixed model was employed for 
the analysis of the CBF and PETCO2 responses to each 0.1ºC increase in core body 
temperature. If any hot flushes occurred during heat stress the CBF and PETCO2 data during 
such episodes were excluded from the CBF and PETCO2 data analyses. Due to variable 
individual increments in core body temperature during the passive heat stress, data up to an 
increase of 0.6ºC were used for the CBF and PETCO2 analyses. Statistically significant 
interactions were followed up with the least significant difference (LSD) approach to multiple 
comparisons. 
46
  
Results 
 
Participants undertaking the exercise intervention demonstrated 93% compliance to the 
exercise sessions. Following adjustment for baseline values, the body mass normalised 
change in VO2peak was 4.5 (1.9-8.2) ml·kg
-1
·min
-1
 greater in the exercise group vs control 
(P=0.04). The absolute change was 21.0 (0.4-41.5) ml·min
-1
 greater in the exercise group vs 
control (P=0.05). The mean frequency of hot flushes per week was 48 (39-56) events lower 
following the exercise intervention vs control (P<0.001). The hot flush severity index was 
109 (80-121) AU lower following exercise training vs control (P<0.001). 
 
Conduit brachial artery endothelial function 
FMD was 2.3% (0.3 to 4.9) greater following exercise training vs control but this did not 
reach statistical significance (P=0.08; Table 1). Baseline and peak diameter did not change 
with either intervention.  
Resting measurements  
Haemodynamics: Heart rate was 4 (2, 5) beats·min
-1
 lower following exercise training vs 
control (P=0.003, Table 2). There were negligible differences in mean arterial pressure, 
cardiac output or stroke volume with the interventions. 
Thermoregulatory: Basal core body temperature was 0.14 (0.01, 0.27) °C lower following 
exercise training vs control in (P=0.03, Table 2). There were negligible differences between 
interventions for basal skin blood flow (Table 2).  Maximal skin blood flow (CVCmax) at the 
arm was 1.2 (-0.1 to 2.4) AU/mmHg greater following exercise training vs control (P=0.05, 
Table 2). This difference was not evident at the chest CVCmax.  
Cerebral Blood Flow: Basal MCAv was 2.8 (1.0 to 5.2) cm/s greater following exercise 
training vs control (P=0.04; Table 2). This improvement was reduced when accounting for 
blood pressure, with cerebral vascular conductance (CBVC) 0.05 (-0.02 to 0.13) cm/s higher 
following exercise training vs control but this did not reach statistical significance (P=0.09; 
Table 2). 
Measurements during the heat stress challenge 
Haemodynamics: Heart rate during heat stress was 5 (1, 10) beats.min
-1
 lower following 
exercise training vs control but this did not reach statistical significance (P=0.08; Table 2). 
Thermoregulatory: There were no differences in the changes in core body temperature (0.07 
(-0.09, 0.24) °C; P=0.40) or weighted mean skin temperature at the end of heating following 
the interventions (0.06 (-0.57, 0.66) °C; P=0.88; Table 2). 
Sweat rate: Mean body temperature for the onset of chest sweating was 0.19 (0.04 to 0.34) 
°C lower following exercise training vs control (P=0.01; Figure 2a). Similarly, mean body 
temperature for the onset of arm sweating was 0.19 (0.05 to 0.36) °C lower following 
exercise training vs control (P=0.01; Figure 2b]. Mean body temperature onset of sweating at 
the chest (r=0.688; P=0.006) and the forearm (r=0.688; P=0.006) following the exercise 
intervention were correlated with the frequency of self-reported hot flushes.  
 
The rate of chest sweating was 0.13 (0.05 to 0.20) mg·cm
2
·min
-1
 greater following exercise 
training vs control (P=0.002; Figure 2c). The rate of forearm sweating was 0.19 (0.05 to 
0.34) mg·cm
2
·min
-1
 greater following exercise training vs control (P=0.01; Figure 2d). 
Cutaneous blood flow: Mean body temperature onset of chest cutaneous vasodilation was a 
0.17 (0.04 to 0.29) °C lower following exercise training vs control (P=0.01; Figure 3a). 
Similarly, the mean body temperature onset of forearm cutaneous vasodilation was 0.15 (0.02 
to 0.28) °C lower following exercise training vs control (P=0.02; Figure 3b).  
 
The rate of cutaneous vasodilation was similar between interventions at the chest (P=0.62; 
Figure 3c) and forearm (P=0.31; Figure 3d).  
Cerebral blood flow 
CBF decreased during the heat stress (P<0.001). There was an intervention*pre/post 
interaction (P<0.001), where the reduction in MCAv during heat stress was attenuated in the 
exercise group vs control (Table 3). MCAv was 4.5 cm/s (3.6, 5.5, P<0.001) higher during 
heating following exercise training vs 0.7 (-0.3, 1.7) cm/s in control (P=0.27). Similarly, 
CBVC decreased during the heat stress (P<0.001). There was a significant 
intervention*pre/post interaction (P=0.01). CBVC was 0.07 (0.04, 0.09) cm·s
-1
·mmHg
-1
 
higher during heat stress in the following exercise (P<0.001) compared to 0.01 (-0.01, 0.03) 
cm·s
-1
·mmHg
-1
 in control P=0.91).  PETCO2 decreased during heat stress (P<0.001), but there 
was no interaction (Table 3; P<0.05). 
Discussion 
The novel findings of the present study were that reductions in self-reported hot flush 
frequency and severity with exercise training coincided with improved thermoregulatory and 
vascular function in symptomatic post-menopausal females. These findings provide evidence 
that improving thermoregulatory and vascular function with moderate-intensity aerobic 
exercise training can be effective in the treatment of hot flushes in post-menopausal females. 
 
Exercise training has been shown in a number of studies to improve the subjective ratings of 
self-reported hot flushes in post-menopausal females 
11-15
, but the underlying physiological 
mechanisms responsible have not yet been investigated. The results of the current study 
suggest that the improvements in the occurrence of post-menopausal hot flushes following 
16-weeks of moderate-intensity aerobic exercise training are linked to improvements in 
thermoregulatory control. We found that exercise training reduces thermoregulatory 
dysfunction via stabilisation of central thermoregulatory control, i.e., lowering core body 
temperature and improving heat dissipation thresholds, alongside improvements in peripheral 
mechanisms that allow for greater heat dissipation (sweating sensitivity). These adaptations 
likely include increases in the number of sweat expulsions per minute, sweat gland 
hypertrophy, increased NO availability, and/or enhanced sweat gland recruitment at a given 
internal temperature, or a combination of all of the above 
47
. Importantly, these findings of 
improved thermoregulatory efficiency with exercise training support previous studies that 
suggest an improvement in VO2peak in the range of ~15-20% mediates positive adaptations to 
thermoregulatory function in pre-menopausal females 
20,48
. This is the first study to 
demonstrate that post-menopausal females can improve thermoregulatory function with 
exercise training, and, importantly, that this contributes to alleviating the frequency and 
severity of hot flushes with exercise training.  
 
The precise mechanisms underlying the pathophysiology of hot flushes is unclear; however it 
is acknowledged that thermoregulatory dysfunction is a key contributing factor 
4,9,49
. Elevated 
basal core body temperature and a narrowing of the thermo-neutral zone (where shivering 
and sweating do not occur) are thought to be responsible for the large, rapid and transient 
increases in skin blood flow, sweating and flushing that characterise hot flushes 
2
. This study 
suggests that improving the control, and stability, of the thermoregulatory system through 
lowering core body temperature and improving heat dissipation mechanisms per se reduces 
the occurrence of hot flushes.  
 
The ability of the blood vessels (including the cutaneous, conduit and cerebral vasculature) to 
vasodilate and thus deliver blood flow systemically is implicated in the pathophysiology of 
hot flushes and also contributes to thermoregulatory control. The reduction in oestrogen 
associated with the menopause causes endothelial dysfunction via decreased NO 
bioavailability 
50
 and/or increased reactive oxygen species scavenging NO 
51
. Exercise 
increases eNOS expression via similar mechanisms of transcriptional regulation to that of 
oestrogen 
52
 and augments NO-mediated vasodilation 
53
. We provide evidence (approaching 
statistical significance) for an improvement in NO-mediated conduit artery endothelial 
function, measured using FMD, following exercise training. Previous studies in post-
menopausal females have not always observed exercise training-mediated increases in 
endothelial function using FMD 
24,25
 but exercise training has been shown to enhance 
cutaneous endothelial function and microvascular reactivity in post-menopausal females 
23,54
. 
One reason for the lack of statistical significant in FMD with exercise training maybe due to 
the vascular remodelling that occurs over the intervention period. Previous studies in young 
healthy males and type 2 diabetic individuals have been shown to improve function (increase 
in FMD) and then normalise due to changes in artery structure/remodelling 
55,56
. Whilst the 
time course of changes in vascular function have not been investigated in post-menopausal 
women, this is the first investigation of exercise-mediated changes in endothelial function in 
symptomatic post-menopausal females. Recent research studies have suggested that 
menopausal hot flushes are associated with greater vascular impairments, including 
endothelial dysfunction 
1
, with FMD a determinant of hot flush severity in early post-
menopausal females 
28
. Therefore, it is likely that symptomatic females have greater 
impairments in endothelial function and increased cardiovascular disease risk, a condition 
that exercise training in this study appears to ameliorate. 
 
Reductions in CBF are evident during a hot flush 
57
 and during a passive heat stress challenge 
58,59
, and thus are implicated in thermoregulatory control via a reduction of blood flow to the 
thermoregulatory centre (hypothalamus) in the brain. Improved basal blood flow to the 
cerebral circulation was observed with exercise training along with attenuation in the 
reduction of CBF typically observed with passive heat stress in the current study. Short-term 
exercise training improves cerebrovascular health across the lifespan 
27
 and our resting CBF 
data support this notion in post-menopausal females. No study to date has examined the 
exercise mediated changes in CBF during passive heat stress, yet given that CBF reductions 
occur during a hot flush (which could be described as a heat stress response per se) it is 
plausible that an exercise mediated attenuation in CBF decreases during heat stress may 
positively impact on cerebrovascular function during a hot flush and possibly other 
perturbations that challenge the maintenance of CBF. The mechanisms responsible for these 
adaptations could include an exercise-mediated increases in stroke volume 
60
 , plasma volume 
expansion 
61
 and/or improved endothelial function as described above 
62
.   
 
An alternative although not mutually exclusive explanation for the improvement in hot flush 
frequency and severity could be related to the central sympathetic nervous system that 
influences the cutaneous, conduit and cerebral vasculature by activating changes in blood 
flow via the noradrenergic and cholinergic systems 
63,64
. Sympathetic noradrenergic nerve 
outflow increases following the menopause 
65
 and elevates peripheral vascular resistance 
66
, 
while sympathetic cholinergic nerve activity is also increased during hot flushes 
67
. 
Moreover, muscle sympathetic nerve activity (MSNA), an index of sympathetic nerve 
activity measured using microneuography, is reduced in post-menopausal females following 
6-months of moderate-intensity cycling exercise alongside improvements in basal forearm 
blood flow 
68
. Such a reduction in basal sympathetic nerve activity could have directly 
reduced the occurrence and/or severity of hot flushes in this study, or indirectly, by reducing 
vascular resistance. 
 
The impact of a reduction in body mass with exercise training on hot flushes also deserves 
consideration. Reductions in BMI were evident with exercise training in the current study in 
accordance with one previous study that reported lower BMI and hot flush symptoms 
following increases in self-reported physical activity 
69
. Whilst the role of obesity on hot 
flush prevalence is unclear, observational studies have reported that females with low 
70
 and 
high 
71
 body fat are at increased risk of hot flushes. Although speculative, increased adiposity 
may increase hot flushes due to elevated insulation and/or affect vascular function via the 
release of adipokines and inflammatory markers from visceral adipose tissue, which could 
decrease with exercise training. It is also important to highlight that an intervention causing 
body mass reduction that did not involve exercise would not mediate the thermoregulatory 
and vascular function improvements observed in the current study 
72
.  
 
Despite the benefits of the exercise training intervention on reducing hot flushes, they were 
not completely abolished following exercise training (~62% reduction in weekly frequency). 
Using various indices, previous studies have reported reductions in hot flush frequency in the 
range of 8-33% 
12,16
 and severity in the range of 10-30% 
12-14,16
. The reasons for the higher 
reductions in frequency and severity in the present study are likely due to differences in 
exercise training programme design (e.g., supervised vs. unsupervised and/or programme 
duration).
12
 In a similar study to ours with supervision and high exercise adherence, Lindh 
and colleagues reported similar reductions in hot flush frequency and severity with exercise 
training 
15
. The frequency and severity responses of the present study mimic those observed 
(~50-72% reduction in hot flushes) following HT administration (i.e. usual clinical care) in 
symptomatic females over 12-weeks 
5
. HT administration over 12-months further reduces hot 
flushes 
6,73
 and thus the effects of exercise training may also further alleviate hot flushes in a 
similar dose-response manner. Despite a reduction in hot flushes with both HT and exercise 
training, it is currently unknown if the effects of exercise and HT act by the same 
mechanisms, via an increase in oestrogen. Whether the combined effects of exercise training 
and HT further improve hot flushes and offset the increases in cardiovascular risk observed 
with HT is worth considering. Furthermore, whether the positive effects of exercise on 
reducing hot flushes remain following cessation of exercise training is currently unknown; 
however it can be speculated that the positive effects may be transient in the absence of 
exercise training i.e. ~4 weeks, in line with the reductions observed in thermoregulatory 
function following the cessation of exercise training in young females 
20
. Nevertheless, the 
findings of the present study suggest that improving thermoregulatory function in 
symptomatic postmenopausal females is beneficial for hot flushes. Although exercise training 
clearly confers improvements in thermoregulatory function these findings also suggest that 
improving thermoregulatory function per se (e.g. passive heat acclimation) may also be of 
benefit for symptomatic postmenopausal females. 
 
One limitation of this study is that it was not a randomised control trial (RCT), with 
participants free to choose which treatment group they entered. Whilst this convenience 
sampling and small sample size limit generalizability these findings are labelled preliminary 
and need to be confirmed in a larger RCT, the reduction in hot flush frequency in the exercise 
group is similar to that observed in previous studies, and the hot flush frequency remained 
unchanged in the control group. Furthermore, thermoregulatory measurements are objective 
and cannot be influenced by the participant 
41
, and were analysed in a blinded fashion. 
Nonetheless, it is acknowledged that the current findings are specific to early post-
menopausal females (1-4y since last menstrual period) that were free of cardiovascular 
disease and not engaged in regular physical activity. The impact of exercise training in 
alleviating hot flushes in individuals with cardiovascular risk factors, or disease, or other 
populations who experience hot flushes (e.g. cancer patients) warrants further research.  
Conclusion 
In summary, improvements in the occurrence of hot flushes with short-term exercise training 
are mediated via thermoregulatory and cardiovascular adaptation(s). This study provides 
mechanistic evidence that exercise training is indeed a useful non-pharmacological 
alternative intervention in the treatment of hot flushes. These findings suggest that targeting 
the thermoregulatory and cardiovascular systems with interventions may be useful in treating 
symptomatic post-menopausal females that suffer from hot flushes. 
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TABLES 
 
Table 1 Anthropometric, hot flash and vascular function data following exercise training or control 
 
Table 2. Resting and heating cardiovascular and thermoregulatory data before and after exercise 
training or control 
 
Table 3. Cerebrovascular responses to 0.1 °C increments in core temperature during passive heat 
stress before and after 16 weeks of exercise training or no-exercise control.  
 
FIGURES 
 
Figure 1. Delta (∆) change from pre-training in mean body temperature threshold for the onset of 
chest (a) and forearm (b) sweating. Delta (∆) change from pre-training in sweat rate sensitivity (slope) 
at the chest (c) and forearm (d). Error bars are SD.*significant difference between exercise and control 
(P<0.05).  
 
Figure 2. Delta (∆) change from pre-training in mean core body temperature threshold values for 
onset of chest (a) and forearm (b) cutaneous vasodilation. Delta (∆) change from pre-training in CVC 
sensitivity at the chest (c) and forearm (d). Error bars are SD. *significant difference between exercise 
and control (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 1 Anthropometric, hot flash and vascular function data following exercise training or control 
 
Variable Pre Exercise Post Exercise Pre Control Post Control P value   
Weight (kg) 77.9 (18.3) 73.5 (16.5)
 
 75.5 (19.9)  75.2 (20.4)  0.02
a
   
BMI (kg/m
2
) 29 (5.8) 27 (4.5)
 
 28 (7.2) 28 (7.0)  0.03
a
   
Systolic (mmHg) 128 (5)    126 (7) 127 (10) 128 (8)               0.25   
Diastolic (mmHg) 78 (8) 75 (7) 77 (11) 77 (9) 0.58   
VO2peak (ml/kg/min) 22.5 (3.3) 27.3 (4.1)
 
 23.2 (2.4) 22.6 (3.1)   0.04
 a
   
VO2peak (L/min) 1.7 (0.4) 2.0 (0.3)
 
 1.7 (0.3) 1.6 (0.4)  0.05
 a
   
Hot Flushes 
Frequency 
(HF·wk) 
64 (20) 23 (13)
 
 45 (21) 49 (36) <0.001
a
   
Severity Index 
(AU) 
137 (49) 37 (22) 91 (49) 102 (70) <0.001
a
   
Vascular Measurements 
FMD (%) 5.0 (1.2) 7.4 (1.5) 5.6 (1.9) 5.5 (1.8) 0.08   
Baseline Diameter 
(mm) 
0.37 (0.03) 0.37 (0.05) 0.36 (0.04) 0.35 (0.04) 0.97   
Peak Diameter 
(mm) 
0.39 (0.04) 0.40 (0.04) 0.38 (0.04) 0.37 (0.04) 0.86   
Shear rateAUC (s
-1 
x 
10
3
) 
16.3 (8.6) 17.8 (10.4) 21.5 (13.9) 20.4 (12.8) 0.95   
Time to Peak (s) 69.7 (32.5) 54.2 (34.6) 70.5 (33.2) 76.7 (35.6) 0.19   
Data are presented as mean (SD.). 
a
Significant difference between change (∆) in Exercise and ∆ in Control values (P<0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Resting and heating cardiovascular and thermoregulatory data before and after exercise training or control 
Variable    Pre Exercise          Post Exercise                         Pre Control             Post Control P value 
Resting      
Heart Rate (b·min
-1
) 64 (7) 60 (7) 66 (11) 65 (12) 0.003
a
 
MAP (mmHg) 75 (7) 75 (5) 76 (4) 75 (6) 0.58 
Stroke Volume (ml) 109 (16) 114 (27) 105 (18) 103 (16) 0.47 
Cardiac Output (l·min
-1
) 7.2 (1.6) 7.6 (1.8) 7.1 (1.4) 7.3 (1.1) 0.69 
Core Temperature (°C) 36.93 (0.19) 36.79 (0.21) 
 
36.86 (0.31) 36.84 (0.27) 
 
  0.03
a
 
Skin Temperature (°C) 32.2 (0.7) 32.9 (0.6) 32.8 (0.5) 32.9 (0.7) 0.10 
MCAv (cm·s
-1
) 51  (6) 54  (7) 51  (5) 51  (5)  0.05
a
 
CBVC (cm·s
-1
·mmHg
-1
) 0.69  (0.11) 0.74 (0.13) 0.68 (0.06) 0.69 (0.04) 0.08 
PETCO2 (Torr) 42 (2) 42 (2) 41 (3) 42 (2) 0.36 
CVCchest (%CVCmax) 10.9 (5.0) 11.2 (6.9) 9.5 (4.5) 8.6 (3.2) 0.93 
CVCarm,  (%CVCmax)                                9.7 (5.2) 10.2 (5.6) 8.8 (4.5) 9.5 (3.3) 0.13 
Chest CVCmax (LDF/mmHg) 
 
5.1  (1.6) 5.9 (1.4) 5.4 (1.1) 5.2 (1.4) 0.58 
Arm CVCmax (LDF/mmHg) 2.9 (0.7) 3.9 (0.9) 3.3 (0.9) 3.4 (0.8)   0.05
a
 
Heating      
Heart Rate (b·min
-1
) 93 (10) 88 (12) 89 (9) 93 (9)  0.08
 
 
Core Temperature (°C) 37.75 (0.17) 37.71 (0.21) 37.63 (0.22) 37.58 (0.24)  0.40 
Skin Temperature (°C) 37.3 (0.7) 37.2 (0.8) 36.9 (0.4) 36.9 (0.5)  0.88 
Data are presented as mean (SD). 
a
significant difference between change ∆ in Exercise and ∆ in Control 
 
 
 
 
 
 
 
 
                   
 
Table 3. Cerebrovascular responses to 0.1 °C increments in core temperature during passive heat stress before and after 16 weeks of exercise training or no-exercise control. 
 
Variable                                                                                                                            
                                                                                                           Exercise Training 
 
 Pre  Post 
Core temp 
°C 
 
Rest 0.1 0.2 0.3 0.4 0.5 0.6  Rest 0.1 0.2 0.3 0.4 0.5 0.6 
MCAv  
cm·s
-1
 
51 (6) 
 
50 (7) 47 (7) 45 (7) 43  (9) 43 (8) 42 (8)  54 (7) 54 (7) 51 (8) 50 (8) 49 (9) 48 (9) 48 (10) 
CBVC 
cm·s
-
1
·mmHg
-1
 
.69 (.08) .67 (.08) .65 (.08) .63 (.08) .60 (.09) .60 (.12) .59 (.09)  .74 (.06) .74 (.07) .70 (.06) .69 (.04) .68 (.05) .67 (.08) .68 (.05) 
PETCO2 
(Torr) 
42 (4) 42 (5) 41 (5) 40 (6) 40 (6) 39 (5) 39 (5)  42 (3) 42 (4) 40 (6) 40 (5) 40 (4) 39 (3) 39 (5) 
                
                                                                                                                     Control 
 Pre  Post 
Core temp 
°C 
Rest 0.1 0.2 0.3 0.4 0.5 0.6 
 
 Rest 0.1 0.2 0.3 0.4 0.5 0.6 
MCAv  
cm·s
-1
 
51 (5) 50 (5) 49 (5) 48 (6) 47 (6) 44 (5) 41 (6) 
 
 51 (5) 50 (4) 48 (4) 46 (4) 44 (4) 44 (6) 43 (6) 
CBVC 
cm·s
-
1
·mmHg
-1
 
.68 (.06) .68 (.07) .67 (.08) .66 (.05) .64 (.07) .61 (.10) .60 (.09)  .69 (.05) .68 (.03) .66 (.04) .65 (.05) .64 (.06) .62 (.07) .61 (.08) 
PETCO2 
(Torr) 
41 (5) 41 (6) 41 (6) 40 (8) 39 (6) 39 (5) 38 (6)  42 (5) 42 (5) 41 (5) 40 (7) 40 (5) 39 (5) 39 (5) 
Data are presented as mean (SD). P values for MCAv (intervention P=0.83, pre/post P<0.0001, intervention*pre/post interaction P<0.001, intervention*pre/post*temp interaction P=0.52), CBVC 
(intervention P=0.84, pre/post P<0.0001, intervention*pre/post interaction P<0.05, intervention*pre/post*temp interaction P=0.65) and PETCO2 (intervention P=0.79, pre/post P< 0.001, 
intervention*pre/post interaction P=0.47, intervention*pre/post*temp interaction P=0.59). 
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